NATIONAL VENTURE CAPITAL ASSOCIATION for NATIONAL VENTURE CAPITAL ASSOCIATION

Immigration IMM

Support for S.310, Startup Act 3.0; S.169 Immigration Innovation Act of 2013; S.189 Startup VISA Act of 2013; Gang of 8 Bipartisan Framework for Comprehensive Immigration Reform; Invest VISA, Entrepreneurial VISA, HR 2131 S744 Border Security, Economic Opportunity and Immigration Modernization Act

Contacted: Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 189 (113th), S. 169 (113th), H.R. 2131 (113th), S. 310 (113th)

Banking BAN

Implementation of Dodd-Frank Wall Street Reform and Consumer Protection Act (PL 111-203) Implementation of the JOBS Act Review of decimalization study by the SEC, required under the JOBS Act

Contacted: White House Office; Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); SENATE; Treasury, Dept of; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

S.232/HR 1295 Medical Device Access and Innovation Protection Act: would appeal the medical device tax as part of the ACA; S. Con Resolution 8: an original resolution setting forth the Congressional Budget for FY2014 which would repeal the medical device tax but not identify a pay for: HR 523 Protect the Medical Innovation Act of 2013 Taxation of carried interest; capital gains tax policy; energy tax extenders; Energy Innovation Tax; Ways and Means "partnership" tax reform discussion draft; Senate Finance tax discussion drafts.

Contacted: SENATE; Securities & Exchange Commission (SEC); Treasury, Dept of; HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); White House Office

Bills named: H.R. 1295 (113th), H.R. 523 (113th), S. 232 (113th)

Telecommunications TEC

HR 1468 Secure IT Act: Bills to protect critical infrastructure against cyber based espionage, IP theft and terror attacks; Privacy and Information Sharing issues; S.21 Cybersecurity and American Cyber Competitiveness Act of 2013; HR 624 Cyber Intelligence Sharing and Protection Act (CISPA)

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Treasury, Dept of; SENATE; Food & Drug Administration (FDA); Securities & Exchange Commission (SEC)

Bills named: H.R. 624 (113th), S. 21 (113th), H.R. 1468 (113th)

Copyright/Patent/Trademark CPT

HR 3309, S.1720, S.1612, S.1013, 5.806 -- various patent reform bills

Contacted: HOUSE OF REPRESENTATIVES; White House Office; Treasury, Dept of; Food & Drug Administration (FDA); Securities & Exchange Commission (SEC); SENATE

Bills named: S. 1013 (113th), S. 1720 (113th), H.R. 3309 (113th), S. 1612 (113th)

Health Issues HCR

No bill #: Lobbied Congress to work the FDA to create a new approval pathway that could help expedite the development of certain drugs that address unmet medical needs, referred to as a special medical use pathway which can be used for a broad set of discussions No bill #: Lobbied Congress on the need for a transparent regulatory pathway for market-based reimbursement for advanced diagnostics. FDA Medical Mobile apps

Contacted: HOUSE OF REPRESENTATIVES; SENATE; White House Office; Food & Drug Administration (FDA); Treasury, Dept of; Securities & Exchange Commission (SEC)

Energy/Nuclear ENG

Cleantech and Energy Policy Issues. New Energy Innovation Tax issues; ARPA-E Funding; HR 2609 FY 2014 Energy and Water Appropriations. Senate Finance Energy Tax Paper

Contacted: HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Treasury, Dept of; White House Office; SENATE

Bills named: H.R. 2609 (113th)

Science/Technology SCI

Basic science research funding HR 2981 Technology and Research National Security and Future Economic Resiliency Act (TRANSFER Act)

Contacted: Food & Drug Administration (FDA); Treasury, Dept of; Securities & Exchange Commission (SEC); SENATE; HOUSE OF REPRESENTATIVES; White House Office

Bills named: H.R. 2981 (113th)